Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Medvance selects TrialStat EDC platform for medical device study

TrialStat : 17 September, 2007  (New Product)
TrialStat has continued its international growth with Medvance Clinical Research’s (Medvance) selection of ClinicalAnalytics 4.0 (CA) as its electronic data capture (EDC) platform for a medical device study.
Based in the UK, Medvance, a contract research organization (CRO), chose CA for its user configurability, ease of use, responsive customer service and attractive subscription pricing model. For nearly 10-years, Medvance has been providing services and solutions to the medical device, pharmaceutical and healthcare industries in the UK.

CA’s100 percent browser configurable platform allows research professionals to deploy study specific EDC nearly twice as fast as the industry average.

TrialStat’s on demand EDC platform also integrates web and flexible data capture technologies, including image-based forms, standalone and handheld devices. CA is fully compliant with international regulatory standards, including the FDA's 21 CFR Part 11 and the good electronic clinical trial practices required by the European Medicines Agency (EMEA) and Health Canada.

“As a fast growing CRO, we wanted an EDC partner that could deliver data management, study design and data archiving all under one roof,” said Janette Benaddi, chief executive officer, Medvance. “These value-added services along with the flexibility of CA allowed us to deploy our study quickly, which has enhanced our ability to deliver results efficiently and cost-effectively for our client.”

“Medical device companies and their CROs require a nimble on demand EDC solution that can be up and running quickly to address this sector’s specific needs,” said Jonathan Barker, president and CEO, TrialStat. “CA provides an optimal combination of speed and ease-of-use that lets customers manage their trials cost-effectively, eliminating those capital expenditures typically associated with client server and ASP software environments. In addition, our partnership with Medvance has further expanded the number of clinical studies hosted by TrialStat outside of the Americas. TrialStat’s significant experience in working with different regulatory jurisdictions and in multiple languages continues to be a critical factor in our ability to deliver excellent products and services to our global customer base.”
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo